<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04786379</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #E21085</org_study_id>
    <nct_id>NCT04786379</nct_id>
  </id_info>
  <brief_title>Surgical Management of Knee Septic Arthritis</brief_title>
  <official_title>Open vs Arthroscopic Treatment of Septic Arthritis in the Adult Native Knee: A Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center, El Paso</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical excisional debridement is the mainstay of management in septic arthritis with&#xD;
      necessary decompression, lavage, debridement, and partial synovectomy. However, there has&#xD;
      been considerable debate over the optimal modality. Most surgeons perform an open arthrotomy&#xD;
      or arthroscopic debridement, although serial aspiration can be considered as an option in&#xD;
      very limited circumstances with patients who cannot tolerate surgery. While open arthrotomy&#xD;
      has been often utilized, there has been an increasing number of proponents for arthroscopic&#xD;
      treatment citing lower re-infection rates and better functional outcomes. However, there has&#xD;
      been a lack of well-designed prospective studies comparing surgical treatment modalities for&#xD;
      native knee septic arthritis. The goals of this present study are to determine if&#xD;
      arthroscopic management of septic arthritis in the native knee resulted in a lower number of&#xD;
      surgeries and a shorter length of stay compared to open arthrotomy. Secondary outcomes&#xD;
      included differences in postoperative pain and improvements in Lysholm knee scores.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients who are diagnosed with septic arthritis of the native knee will be randomized to either arthroscopic or open treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of surgeries to obtain lasting clinical resolution</measure>
    <time_frame>Through time period of initial admission (days; expected under 14 days)</time_frame>
    <description>The total number of surgeries performed during initial admission in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Through time period of initial admission (days; expected under 14 days)</time_frame>
    <description>The total number of days in which the patient is initially admitted in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Pain Scores</measure>
    <time_frame>Through time period of initial admission (days; expected under 14 days)</time_frame>
    <description>Daily morning and afternoon visual analogue scale reported by nursing staff. This value is reported on a scale of 0-10; a score of 0 indicates no pain while 10 indicates unbearable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Opioid Use</measure>
    <time_frame>Through time period of initial admission (days; expected under 14 days)</time_frame>
    <description>All patients will have post operative pain medications which are to be utilized in a step wise manner for treating their pain. For example, if they are in minimal pain they will be given tylenol whereas unbearable pain will be treated with opioid analgesics. The average total post-operative opioid usage during initial admission will be reported as total morphine milligram equivalent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lysholm Knee Scale</measure>
    <time_frame>Through anticipated follow up period of 3 month post operative appointment.</time_frame>
    <description>The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting. The scoring is between 0-100 points. A score of &lt;65 indicates poor knee function, 65-83 indicates fair knee function, 84-94 indicates a fair outcome, and 95-100 indicates excellent knee function. This scoring system will be obtained at 2 week, 6 week, and 3 months.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Septic Arthritis</condition>
  <arm_group>
    <arm_group_label>Patients with confirmed septic arthritis of the native knee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic Irrigation and Debridement</intervention_name>
    <description>Patients with confirmed septic arthritis treated with multiple small incisions to perform irrigation and debridement with partial synovectomy.</description>
    <arm_group_label>Patients with confirmed septic arthritis of the native knee</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Arthrotomy with irrigation and debridement</intervention_name>
    <description>Patients with confirmed septic arthritis treated with a single large incision, open arthrotomy to perform irrigation and debridement with partial synovectomy.</description>
    <arm_group_label>Patients with confirmed septic arthritis of the native knee</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (&gt;18 years old)&#xD;
&#xD;
          -  Have a diagnosis of septic arthritis of the native knee (synovial WBC &gt;50k or&#xD;
             acrystalline elevated synovial WBC &gt;25,000 with high clinical suspicion)&#xD;
&#xD;
          -  Willingness to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling to participate in the study&#xD;
&#xD;
          -  Acrystalline elevated synovial WBC &lt; 25,000&#xD;
&#xD;
          -  Crystalline arthropathy with elevated synovial WBC but &lt; 50,000&#xD;
&#xD;
          -  Have a history of a prior knee prosthesis (hemiarthroplasty, total knee arthroplasty)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Adler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Texas Tech University Health Sciences Center of El Paso</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew E Wells, DO</last_name>
    <phone>915-215-5400</phone>
    <email>matthew.wells@ttuhsc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center of El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Wells, DO</last_name>
      <email>matthew.eric.wells@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hunter JG, Gross JM, Dahl JD, Amsdell SL, Gorczyca JT. Risk factors for failure of a single surgical debridement in adults with acute septic arthritis. J Bone Joint Surg Am. 2015 Apr 1;97(7):558-64. doi: 10.2106/JBJS.N.00593.</citation>
    <PMID>25834080</PMID>
  </reference>
  <reference>
    <citation>Böhler C, Dragana M, Puchner S, Windhager R, Holinka J. Treatment of septic arthritis of the knee: a comparison between arthroscopy and arthrotomy. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3147-3154. Epub 2015 May 28.</citation>
    <PMID>26017744</PMID>
  </reference>
  <reference>
    <citation>Wirtz DC, Marth M, Miltner O, Schneider U, Zilkens KW. Septic arthritis of the knee in adults: treatment by arthroscopy or arthrotomy. Int Orthop. 2001;25(4):239-41.</citation>
    <PMID>11561499</PMID>
  </reference>
  <reference>
    <citation>Aïm F, Delambre J, Bauer T, Hardy P. Efficacy of arthroscopic treatment for resolving infection in septic arthritis of native joints. Orthop Traumatol Surg Res. 2015 Feb;101(1):61-4. doi: 10.1016/j.otsr.2014.11.010. Epub 2015 Jan 23.</citation>
    <PMID>25623272</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2021</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University Health Sciences Center, El Paso</investigator_affiliation>
    <investigator_full_name>Matthew Wells</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>orthopedic</keyword>
  <keyword>septic arthritis</keyword>
  <keyword>synovectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Infectious</mesh_term>
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 19, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT04786379/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 19, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT04786379/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

